• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    125.88 Down 0.34(0.27%) Aug 4, 4:00PM EDT
    |After Hours : 125.90 Up 0.02 (0.01%) Aug 4, 4:57PM EDT
    Add to Portfolio
    Prev Close:126.22
    Open:126.73
    Bid:110.30 x 100
    Ask:132.02 x 100
    1y Target Est:143.40
    Beta:2.03
    Next Earnings Date: 6-Aug-15ALNY Earnings announcement
    Day's Range:123.73 - 128.59
    52wk Range:53.54 - 140.00
    Volume:429,993
    Avg Vol (3m):760,636
    Market Cap:10.61B
    P/E (ttm):N/A
    EPS (ttm):-2.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALNY

    Comparison

    Symbol% ChgMkt Cap
    ALNYDown 0.27%10.61B
    MRKDown 0.59%165.84B
    PFEDown 0.11%222.35B
    VRXUp 1.08%89.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):174.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.03
    Quarterly EPS Est (Jun-15) :-0.75
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.90

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. The company’s clinical development programs include Patisiran and Revusiran, which are in Phase ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback